首页|期刊导航|甘肃医药|子宫内膜癌患者术后早期应用低分子肝素对凝血-纤溶平衡及复发风险的影响研究

子宫内膜癌患者术后早期应用低分子肝素对凝血-纤溶平衡及复发风险的影响研究OA

Effect of early postoperative low-molecular-weight heparin application on coagulation-fibrinolysis balance and recurrence risk in patients with endometrial cancer

中文摘要英文摘要

目的:探讨子宫内膜癌患者术后早期应用低分子肝素(LMWH)对凝血-纤溶平衡的调节作用及对肿瘤复发风险的影响.方法:选取2022年1 月至2025年12月于甘肃省肿瘤医院行根治性手术治疗的子宫内膜癌患者 110例,按随机数字表法分为观察组(55例)和对照组(55例).对照组术后给予常规对症支持治疗,观察组在对照组基础上于术后第 1 天开始予低分子肝素钙 4100 IU 皮下注射,每日 1 次,连续 10 d.比较两组术前及术后 2 周凝血功能指标(PT、APTT、FIB)、纤溶指标(D-二聚体)及血小板计数(PLT)水平,记录术后下肢深静脉血栓(DVT)及出血事件发生率,随访24个月统计术后复发率.结果:术后2周,观察组D-二聚体、FIB水平均低于对照组(P<0.01);两组PT、APTT、PLT 比较无统计学差异(P>0.05).观察组术后 DVT 发生率为 3.77%,低于对照组的 14.81%(χ2=3.849,P=0.050);两组出血事件发生率比较无统计学差异(5.66%vs.1.85%,P=0.360).两组术后 24 个月复发率比较无统计学差异(12.73%vs.16.36%,P=0.590).结论:子宫内膜癌患者术后早期应用低分子肝素能够有效改善凝血-纤溶平衡,降低术后DVT发生风险,且不增加出血事件,但对术后2年内肿瘤复发率未见影响.

Objective:To investigate the regulatory effect of early postoperative low molecular weight heparin(LMWH)on coagula-tion-fibrinolysis balance and its impact on tumor recurrence risk in patients with endometrial cancer.Methods:A total of 110 patients with endometrial cancer who underwent radical surgery at Gansu Provincial Cancer Hospital from January 2022 to December 2025 were selected and randomly divided into an observation group(n=55)and a control group(n=55)using a random number table.The control group received conventional symptomatic supportive therapy postoperatively,while the observation group received subcutaneous injections of low-molecu-lar-weight heparin calcium 4100 IU once daily starting on postoperative day 1 for 10 consecutive days.Coagulation function parameters(PT,APTT,FIB),fibrinolysis parameter(D-dimer),and platelet count(PLT)were compared between the two groups before surgery and at 2 weeks postoperatively.The incidences of postoperative deep vein thrombosis(DVT)and bleeding events were recorded,and the postoperative tumor recurrence rate was analyzed at the 24-month follow-up.Results:At 2 weeks postoperatively,the D-dimer and FIB levels in the observation group were significantly lower than those in the control group(P<0.01).No significant differences were observed in PT,APTT,or PLT levels between the two groups(P>0.05).The DVT incidence rate in the observation group was 3.77%,significantly lower than that in the control group(14.81%)(χ2=3.849,P=0.050).There was no significant difference in bleeding event rates between the two groups(5.66%vs.1.85%,P=0.360).The 24-month recurrence rates were also comparable between the two groups(12.73%vs.16.36%,P=0.590).Conclusions:Early postoperative administration of low-molecular-weight heparin in patients with endometrial cancer can effectively improve coagulation-fibrinolysis balance,and reduce the risk of postoperative deep vein thrombosis(DVT)without increasing the risk of bleeding events.However,it showed no signifi-cant impact on the tumor recurrence rate within 2 years after surgery.

崔静;丁燕;胡拓阳;李飞霞;朱姣姣;常晓英;王雨村

甘肃省肿瘤医院,甘肃 兰州 730050甘肃省肿瘤医院,甘肃 兰州 730050甘肃省肿瘤医院,甘肃 兰州 730050甘肃省肿瘤医院,甘肃 兰州 730050甘肃省肿瘤医院,甘肃 兰州 730050甘肃省肿瘤医院,甘肃 兰州 730050甘肃省肿瘤医院,甘肃 兰州 730050

医药卫生

子宫内膜癌低分子肝素凝血功能纤溶平衡复发风险深静脉血栓

endometrial cancerlow-molecular-weight heparincoagulation functionfibrinolytic balancerecurrence riskdeep vein thrombosis

《甘肃医药》 2026 (7)

595-599,5

甘肃省卫生健康行业科研计划项目(编号:GSWSKY2021-027)

10.15975/j.cnki.1004-2725.2026.07.005

评论